Advance your academic career, collaborate globally, and expand your network— join now !

Sanjay Garg

Prof. Dr. Sanjay Garg

University of South Australia

Share Link

Share

Information

Sanjay Garg is a Professor at the School of Pharmacy and Medical Sciences, University of South Australia. As the Co-Director of the Centre for Pharmaceutical Innovation (CPI) and leader of the Pharmaceutical Innovation and Development Group (PIDG), he is committed to pioneering cutting-edge research and innovative solutions. His patented formulations have reached clinical stages and markets in the USA, India, New Zealand, UK, and Australia, such as Acidform (USA Patent 6706276), which is FDA-approved as a non-hormonal contraceptive (Phexxi) and marketed in the USA as a prescription product. During his tenure at the University of Auckland, New Zealand, he established a Good Laboratory Practice (GLP)-compliant analytical laboratory and played a pivotal role in creating research and post-graduate programs at the Auckland Pharmacy School. He was awarded the APSA Medal by the Australasian Pharmaceutical Science Association in 2015. He has published 253 papers with 11,321 citations and an h index of 50 (Scopus, 19 October 2023). His research topics mainly include transforming industries, cancer, healthy futures, nano-carriers, 3D printing; drug delivery, drug targeting, microbicides, nanomedicine, superbugs, and drug development.

Research Keywords & Expertise

Cancer
Drug Delivery
Nanotechnology
Pharmacy
infections

Fingerprints

24%
Drug Delivery
20%
Cancer
13%
infections
5%
Pharmacy
5%
Nanotechnology

Short Biography

Sanjay Garg is a Professor at the School of Pharmacy and Medical Sciences, University of South Australia. As the Co-Director of the Centre for Pharmaceutical Innovation (CPI) and leader of the Pharmaceutical Innovation and Development Group (PIDG), he is committed to pioneering cutting-edge research and innovative solutions. His patented formulations have reached clinical stages and markets in the USA, India, New Zealand, UK, and Australia, such as Acidform (USA Patent 6706276), which is FDA-approved as a non-hormonal contraceptive (Phexxi) and marketed in the USA as a prescription product. During his tenure at the University of Auckland, New Zealand, he established a Good Laboratory Practice (GLP)-compliant analytical laboratory and played a pivotal role in creating research and post-graduate programs at the Auckland Pharmacy School. He was awarded the APSA Medal by the Australasian Pharmaceutical Science Association in 2015. He has published 253 papers with 11,321 citations and an h index of 50 (Scopus, 19 October 2023). His research topics mainly include transforming industries, cancer, healthy futures, nano-carriers, 3D printing; drug delivery, drug targeting, microbicides, nanomedicine, superbugs, and drug development.